Your browser doesn't support javascript.
loading
The genetic risk factor CEL-HYB1 causes proteotoxicity and chronic pancreatitis in mice.
Fjeld, Karianne; Gravdal, Anny; Brekke, Ranveig S; Alam, Jahedul; Wilhelm, Steven J; El Jellas, Khadija; Pettersen, Helene N; Lin, Jianguo; Solheim, Marie H; Steine, Solrun J; Johansson, Bente B; Njølstad, Pål R; Verbeke, Caroline S; Xiao, Xunjun; Lowe, Mark E; Molven, Anders.
Afiliación
  • Fjeld K; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway. Electronic address: kar
  • Gravdal A; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Brekke RS; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Alam J; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway.
  • Wilhelm SJ; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • El Jellas K; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway.
  • Pettersen HN; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway.
  • Lin J; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Solheim MH; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway.
  • Steine SJ; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Johansson BB; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway.
  • Njølstad PR; Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway; Pediatric and Youth Clinic, Haukeland University Hospital, Bergen, Norway.
  • Verbeke CS; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway; Department of Pathology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Xiao X; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Lowe ME; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Molven A; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway; Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway.
Pancreatology ; 22(8): 1099-1111, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36379850
ABSTRACT
BACKGROUND &

AIMS:

The CEL gene encodes the digestive enzyme carboxyl ester lipase. CEL-HYB1, a hybrid allele of CEL and its adjacent pseudogene CELP, is a genetic variant suggested to increase the risk of chronic pancreatitis (CP). Our aim was to develop a mouse model for CEL-HYB1 that enables studies of pancreatic disease mechanisms.

METHODS:

We established a knock-in mouse strain where the variable number of tandem repeat (VNTR) region of the endogenous mouse Cel gene was substituted with the mutated VNTR of the human CEL-HYB1 allele. Heterozygous and homozygous Cel-HYB1 mice and littermate wildtype controls were characterized with respect to pancreatic pathology and function.

RESULTS:

We successfully constructed a mouse model with pancreatic expression of a humanized CEL-HYB1 protein. The Cel-HYB1 mice spontaneously developed features of CP including inflammation, acinar atrophy and fatty replacement, and the phenotype became more pronounced as the animals aged. Moreover, Cel-HYB1 mice were normoglycemic at age 6 months, whereas at 12 months they exhibited impaired glucose tolerance. Immunostaining of pancreatic tissue indicated the formation of CEL protein aggregates, and electron microscopy showed dilated endoplasmic reticulum. Upregulation of the stress marker BiP/GRP78 was seen in pancreatic parenchyma obtained both from Cel-HYB1 animals and from a human CEL-HYB1 carrier.

CONCLUSIONS:

We have developed a new mouse model for CP that confirms the pathogenicity of the human CEL-HYB1 variant. Our findings place CEL-HYB1 in the group of genes that increase CP risk through protein misfolding-dependent pathways.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pancreatitis Crónica / Lipasa Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Animals / Humans / Infant Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pancreatitis Crónica / Lipasa Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Animals / Humans / Infant Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article